Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

AT&T Surpasses Q1 Revenue Estimates


Telecommunications giant AT (NYSE:T) reported fiscal 2025 first quarter earnings on Wednesday, April 23, that matched or exceeded analysts' consensus expectations. Revenue of $30.63 billion came in ahead of the forecasted $30.36 billion and rose 2% year over year. Adjusted earnings per share (EPS) reached $0.51, aligning with market expectations.

The first quarter showcased AT's focus on enhancing its 5G and fiber optic services, contributing to a solid quarter despite ongoing market challenges in segments such as its Business Wireline segment.

Source: AT Note: Analysts' consensus estimates for the quarter provided by FactSet. YOY = Year over year.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

?
0,00 %
Unverändert bleibt Allergy Therapeutics PLC, keine Bewegung im täglichen Rhythmus.

Like: 0
T
Teilen

Kommentare